Search Results - "Tijssen, J.G.P."

PAIS 2 (Paracetamol [Acetaminophen] in Stroke 2): Results of a Randomized, Double-Blind Placebo-Controlled Clinical Trial by de Ridder, Inger R, den Hertog, Heleen M, van Gemert, H. Maarten A, Schreuder, A.H.C.M.L (Tobien), Ruitenberg, Annemieke, Maasland, E (Lisette), Saxena, Ritu, van Tuijl, Jordie H, Jansen, Ben P.W, Van den Berg-Vos, Renske M, Vermeij, Frederique, Koudstaal, Peter J, Kappelle, L Jaap, Algra, Ale, van der Worp, H Bart, Dippel, Diederik W.J, Lingsma, H.F, El Ghannouti, N, Vermey, F, Vermeulen, M, Tijssen, J.G.P, van Dijk, E.J

“…BACKGROUND AND PURPOSE—Subfebrile body temperature and fever in the first days after stroke are strongly associated with unfavorable outcome. A subgroup…”
Get full text

Nurses' perspectives on nurse-coordinated prevention programmes in secondary prevention of cardiovascular disease: a pilot survey by Jorstad, H.T., Chan, Y.K., Scholte op Reimer, W.J.M., Doornenbal, J., Tijssen, J.G.P., Peters, R.J.G.

“…Background: Secondary prevention of coronary artery disease (CAD) is increasingly provided by nurse-coordinated prevention programs (NCPP). Little is known…”
Get full text

Cost-effectiveness of early versus selectively invasive strategy in patients with acute coronary syndromes without ST-segment elevation by Dijksman, L.M, Hirsch, A, Windhausen, F, Asselman, F.F, Tijssen, J.G.P, Dijkgraaf, M.G.W, de Winter, R.J

“…Abstract Aims The ICTUS trial compared an early invasive versus a selectively invasive strategy in high risk patients with a non-ST-segment elevation acute…”
Get full text

Validity of conjoint analysis to study clinical decision making in elderly patients with aortic stenosis by Bouma, B.J., van der Meulen, J.H.P., van den Brink, R.B.A., Smidts, A., Cheriex, E.C., Hamer, H.P., Arnold, A.E.R., Zwinderman, A.H., Lie, K.I., Tijssen, J.G.P.

“…Written case simulations are increasingly being used to investigate clinical decision making. Our study was designed to determine the validity of written case…”
Get full text

The effect of low-dose colchicine on cause-specific mortality in the LoDoCo2 trial by Opstal, T.S.J., Nidorf, S.M., Fiolet, A.T.L., Eikelboom, J.W., Mosterd, A., Thompson, P.L., Budgeon, C., Tijssen, J.G.P., Bax, W.A., Cornel, J.H.

Get full text

Four-year results of the AIDA trial: comparison of Absorb bioresorbable scaffold with Xience everolimus-eluting metallic stent in daily clinical practice by Kerkmeijer, L.S.M, Tijssen, R.Y.G, Kraak, R.P, Hofma, S.H, Arkenbout, E.K, Van Der Schaaf, R.J, Weevers, A.P.J, Tijssen, J.G.P, Piek, J.J, Henriques, J.P.S, De Winter, R.J, Wykrzykowska, J.J

“…Abstract Aims Absorb bioresorbable scaffold (BRS) related events were noticed between 1 and 3 years – the approximate time of active scaffold bioresorption…”
Get full text

Two-year clinical performance of Absorb BVS compared to Xience EES in ST-segment elevation myocardial infarction: a pooled analysis of AIDA and COMPARE-ABSORB trials by Kerkmeijer, L.S.M, Chao, G, Tijssen, R, Gori, T, Kraak, R.P, Tijssen, J.G.P, Onuma, Y, Chevalier, B, De Winter, R.J, Smits, P, Van Geuns, R.J, Wykrzykowska, J.J

“…Abstract Introduction Bioresorbable vascular scaffolds (BVS) use appears theoretically attractive in patients presenting with ST-segment elevation myocardial…”
Get full text

Sa1939 DUODENAL MUCOSAL RESURFACING COMBINED WITH GLP-1 RECEPTOR AGONISM MAY ELIMINATE INSULIN TREATMENT IN TYPE 2 DIABETES WHILE IMPROVING GLYCEMIC CONTROL AND OVERALL METABOLIC HEALTH by Meiring, Suzanne, van Baar, Annieke, Smeele, Paul, Vriend, Tessa, Holleman, Frits, Barlag, Marjon, Mostafavi, Nahid, Tijssen, J.G.P., Soeters, M.R., Nieuwdorp, Max, Bergman, Jacques

Get full text

Effects of age on long-term outcomes after a routine invasive or selective invasive strategy in patients presenting with non-ST segment elevation acute coronary syndromes: a collaborative analysis of individual data from the FRISC II - ICTUS - RITA-3 (FIR) trials by Damman, Peter, Clayton, Tim, Wallentin, Lars, Lagerqvist, Bo, Fox, Keith A A, Hirsch, Alexander, Windhausen, Fons, Swahn, Eva, Pocock, Stuart J, Tijssen, Jan G P, de Winter, Robbert J

“…To perform a patient-pooled analysis of a routine invasive versus a selective invasive strategy in elderly patients with non-ST segment elevation acute…”
Get more information

Acute upper GI bleeding: did anything change?: Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000 by van Leerdam, M.E, Vreeburg, E.M, Rauws, E.A.J, Geraedts, A.A.M, Tijssen, J.G.P, Reitsma, J.B, Tytgat, G.N.J

“…The aim of this study was to examine recent time trends in incidence and outcome of upper GI bleeding. Prospective data collection on all patients presenting…”
Get full text

P2775Twelve year experiences with left ventricular circulatory support with Impella by Ouweneel, D.M., De Brabander, J., Sjauw, K.D., Engstom, A.E., Vis, M.M., Wykrzykowska, J.J., Beijk, M.A., Koch, K.T., Baan, J., De Winter, R.J., Piek, J.J., Lagrand, W.K., De Mol, B.A.J.M., Tijssen, J.G.P., Henriques, J.P.S.

Get full text

Early Invasive Versus Selective Strategy for Non–ST-Segment Elevation Acute Coronary Syndrome by Hoedemaker, Niels P.G., MD, Damman, Peter, MD, PhD, Woudstra, Pier, MD, Hirsch, Alexander, MD, PhD, Windhausen, Fons, MD, PhD, Tijssen, Jan G.P., PhD, de Winter, Robbert J., MD, PhD

“…Abstract Background The ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes) trial compared early invasive strategy with a selective…”
Get full text

Early onset of endothelial cell proliferation in coronary thrombi of patients with an acute myocardial infarction: implications for plaque healing by LI, X., KRAMER, M. C., VAN DER LOOS, C. M., PLOEGMAKERS, H. J. P., DE BOER, O. J., KOCH, K. T., TIJSSEN, J. G. P., DE WINTER, R. J., VAN DER WAL, A. C.

“…Aims  Coronary thrombotic occlusion in ST‐segment elevation myocardial infarction (STEMI) patients is often preceded by episodes of progressive growth of the…”
Get full text

Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial by Liem, A.H, van Boven, A.J, Veeger, N.J.G.M, Withagen, A.J, Robles de Medina, R.M, Tijssen, J.G.P, van Veldhuisen, D.J

“…Aims Residual ischaemia following acute myocardial infarction (AMI) is related to an adverse outcome, although the effect of early initiation of statin therapy…”
Get full text

Cost-effectiveness of perioperative selective decontamination of the digestive tract versus placebo in elective gastrointestinal surgery by Dijksman, L M, Roos, D, Gerhards, M F, Tijssen, J G P, Gouma, D J, Dijkgraaf, M G W

“…We compared the routine use of perioperative selective decontamination of the digestive tract (SDD) for elective gastrointestinal surgery with placebo in a…”
Get more information

Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results by van der Laan, A. M., Hirsch, A., Nijveldt, R., van der Vleuten, P. A., van der Giessen, W. J., Doevendans, P. A., Waltenberger, J., ten Berg, J. M., Aengevaeren, W. R. M., Zwaginga, J. J., Biemond, B. J., van Rossum, A. C., Tijssen, J. G. P., Zijlstra, F., Piek, J. J.

“…During the last decennium, the role of bone marrow mononuclear cells (BMMC) has been underscored in the healing process after acute myocardial infarction…”
Get full text

Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial by Liem, A.H., van Boven, A.J., Veeger, N.J.G.M., Withagen, A.J., Robles de Medina, R.M., Tijssen, J.G.P., van Veldhuisen, D.J.

“…Background: Folic acid is assumed to have favourable effects on vascular endothelium, directly as well as indirectly through its effect on homocysteine…”
Get full text

The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplasty by de Winter, R.J., Heyde, G.S., Koch, K.T., Fischer, J., van Straalen, J.P., Bax, M., Schotborgh, C.E., Mulder, K.J., Sanders, G.T., Piek, J.J., Tijssen, J.G.P.

“…Aims The acute phase reactant C-reactive protein is an important prognostic risk factor in patients with both stable and unstable coronary artery disease. The…”
Get full text

RESPONSE study: Randomised Evaluation of Secondary Prevention by Outpatient Nurse SpEcialists: Study design, objectives and expected results by Jørstad, H. T., Alings, A. M. W., Liem, A. H., von Birgelen, C., Tijssen, J. G. P., de Vries, C. J., Lok, D. J. A., Kragten, J. A., Peters, R. J. G.

“…Background. Patients with coronary artery disease are at high risk of coronary events and death, but effective secondary prevention can reduce this risk. There…”
Get full text

Proximal embolic protection in patients undergoing primary angioplasty for acute myocardial infarction (PREPARE): core lab adjudicated angiographic outcomes of a randomised controlled trial by Haeck, J.D.E., Koch, K.T., Gu, Y.L., Bilodeau, L., Kuijt, W.J., Sjauw, K.D., J.P.S., Henriques, Baan, J., Vis, M.M., Verouden, N.J.W., Groenink, M., Piek, J.J., Tijssen, J.G.P., Krucoff, M.W., Zijlstra, F., de Winter, R.J.

“…Background. Patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI) with the Proxis…”
Get full text